Moreover, the work of Rao et al. suggests that CSF1R inhibition blocks the growth of PDGFB-overexpressing glioma, e.g., proneural glioma with PDGFB over-expression whereas mesenchymal GBMs are resistant to this approach [202]. The gene discussed is CSF1R; the disease is central nervous system cancer.